Article
Author(s):
San Francisco - A baseline examination followed by yearly screening for retinopathy is probably adequate for patients taking chronic antimalarial therapy, Stephen E. Wolverton, M.D., said.
Bridging Therapeutic Innovation and Dermatology
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Nektar Therapeutics Completes Enrollment for Phase 2b REZOLVE-AD Trial of Rezpegaldesleukin
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
State-of-the-State Update: Chronic Hand Eczema
Researchers Develop Recommendations for Hyaluronic Acid Filler Placement in Cases of Hollowness, Volume Deficits